Yes. Thanks to Clarity, TLX has to cannibalise its own product which just got approved and sales are ramping up. Who knew biotech is another disruptive field like technology where the long gestation period of a decade to approval can be upturned in just 2 years by a competitor who also has spent a decade developing a competing product. We are seeing value migration underway from Ga to Cu64. Wait till we see Cu67 destroy radio/ chemo therapies. The Cu64-67 pair can be the magical pair.
AIMO.
Yes. Thanks to Clarity, TLX has to cannibalise its own product...
Add CU6 (ASX) to my watchlist
 (20min delay)
|
|||||
|
Last
$5.57 |
Change
0.480(9.43%) |
Mkt cap ! $1.735B | |||
| Open | High | Low | Value | Volume |
| $5.20 | $5.57 | $5.16 | $14.63M | 2.711M |
Buyers (Bids)
| No. | Vol. | Price($) |
|---|---|---|
| 1 | 6146 | $5.57 |
Sellers (Offers)
| Price($) | Vol. | No. |
|---|---|---|
| $5.60 | 6194 | 4 |
View Market Depth
| Last trade - 16.10pm 11/07/2024 (20 minute delay) ? |
| CU6 (ASX) Chart |